Department of Health and Human Services August 22, 2005 – Federal Register Recent Federal Regulation Documents

National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting
Document Number: 05-16588
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Document Number: 05-16587
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Aging; Notice of Meeting
Document Number: 05-16586
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Document Number: 05-16585
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Child Health and Human Development; Notice of Closed Meeting
Document Number: 05-16584
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
Document Number: 05-16583
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Complementary & Alternative Medicine; Notice of Closed Meetings
Document Number: 05-16582
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
Document Number: 05-16581
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Closed Meeting
Document Number: 05-16580
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases; Notice of Meeting
Document Number: 05-16579
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institutes of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings
Document Number: 05-16578
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of Closed Meetings
Document Number: 05-16577
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Cancer Institute; Notice of Closed Meeting
Document Number: 05-16576
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings
Document Number: 05-16575
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
National Center for Research Resources; Notice of Closed Meetings
Document Number: 05-16574
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, National Institutes of Health
Solicitation of Nominations for Membership on the Secretary's Advisory Committee on Human Research Protections
Document Number: 05-16506
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services
The Office for Human Research Protections (OHRP), a program office in the Office of Public Health and Science, Department of Health and Human Services (HHS), is seeking nominations of qualified candidates to be considered for appointment as members of the Secretary's Advisory Committee on Human Research Protections (SACHRP). SACHRP provides advice and recommendations to the Secretary, HHS, and the Assistant Secretary for Health on matters pertaining to the continuance and improvement of functions within the authority of HHS directed toward protections for human subjects in research. SACHRP was established by the Secretary, HHS, on October 1, 2002. OHRP is seeking nominations of qualified candidates to fill three positions on the Committee membership that will become vacant on January 1, 2006.
Critical Path Initiative; Developing Prevention Therapies; Planning of Workshop; Correction
Document Number: 05-16504
Type: Notice
Date: 2005-08-22
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration is correcting a notice that appeared in the Federal Register of August 3, 2005 (70 FR 44660). The document announced the planning of a workshop as part of its Critical Path Initiative and requested comments. The document was published with an incorrect docket number. This document corrects that error.
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Document Number: 05-16503
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
Advisory Commission on Childhood Vaccines; Notice of Meeting
Document Number: 05-16502
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting
Document Number: 05-16501
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
National Advisory Committee on Rural Health and Human Services; Notice of Meeting
Document Number: 05-16500
Type: Notice
Date: 2005-08-22
Agency: Department of Health and Human Services, Health Resources and Services Administration
Implantation or Injectable Dosage Form New Animal Drugs; Flunixin
Document Number: 05-16499
Type: Rule
Date: 2005-08-22
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental abbreviated new animal drug application (ANADA) filed by Phoenix Scientific, Inc. The supplemental ANADA provides for veterinary prescription use of flunixin meglumine solution by intravenous injection in lactating dairy cattle for control of fever associated with bovine respiratory disease and endotoxemia, and for control of inflammation in endotoxemia.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.